Business

Ford Motor’s U.S. new vehicle sales experienced an 11.2% increase last month compared to the same time last year. The impressive growth was primarily driven by a surge in sales of hybrid and all-electric models. Hybrid and all-electric vehicle sales saw a remarkable 65% increase, overshadowing the modest 5.6% rise in sales of Ford’s traditional
0 Comments
The leadership of Paramount Global recently revealed a comprehensive go-forward plan during the company’s annual shareholder meeting. The plan, outlined by CBS CEO George Cheeks, Paramount Media Networks CEO Chris McCarthy, and Paramount Pictures CEO Brian Robbins, titled the “Office of the CEO”, detailed strategic priorities in the event a sale of the company does
0 Comments
Jeep, a brand under Stellantis, has set an ambitious target to increase U.S. sales of its plug-in hybrid electric vehicles (PHEVs) by up to 50% this year. This decision comes as the automaker sees PHEVs as a crucial bridge between its traditional gas-powered SUVs and the upcoming all-electric models. Amidst a slower-than-expected pace of electric
0 Comments
Recently, Moderna and Merck shared promising three-year data on their innovative vaccine, which was administered to individuals suffering from the deadliest form of skin cancer in conjunction with Keytruda therapy. This groundbreaking combination not only enhanced survival rates but also demonstrated long-lasting efficacy in a midstage research study involving patients with a life-threatening form of
0 Comments
In 2019, Adam Moelis embarked on a journey to revolutionize the way Americans save money by co-founding a fintech startup called Yotta. His vision was to provide consumers with a novel approach to financial stability, allowing them to navigate life’s uncertainties with ease. However, what transpired was far from his intentions. A dispute between Yotta’s
0 Comments
Pfizer’s drug for an advanced form of lung cancer, Lorbrena, has shown promising long-term results in a late-stage trial. The drug has helped patients live longer without cancer progression, with most patients experiencing this benefit for over five years. Additionally, Lorbrena has been found to reduce the risk of cancer progression in the brain, a
0 Comments